华北制药：2025年第一次临时股东大会决议公告

Group 1 - The core point of the article is that North China Pharmaceutical announced the approval of several resolutions at its first extraordinary general meeting of shareholders in 2025, including the cancellation of the supervisory board and amendments to related proposals [2] Group 2 - The company held its first extraordinary general meeting of shareholders on December 15 [2] - The resolutions passed include the cancellation of the supervisory board and amendments to various proposals [2]